Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2013 / The 100 most influential people in TAS / Robert Kennedy

Robert Kennedy

Hobart H. Willard Professor of Chemistry; Professor, Pharmacology, University of Michigan, USA

  • Profile

Meet Robert Kennedy

Highlight: “Although most of our work has been in chemical separations, our development of an electrode to measure insulin secretion at single cells was a surprising success that led to many discoveries about insulin regulation. A close second is the realization of the potential for rapid separation in many areas of chemical analysis.”

Main motivation: “I have always been fascinated by biology. I am motivated by the excitement generated from harnessing the power of new chemical instrumentation to answer both curiosity and disease-centered questions in biological systems.”

Future aspiration: “In the next 10 years, I hope that we can prove the potential of droplet microfluidics for drug discovery, make our in vivo neurochemical analysis methods routine so that they can be used to study the regulation of neurotransmitters, and improve metabolomics to discover underlying causes of diabetes.”

kennedygroup.lsa.umich.edu

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.